KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 103 filers reported holding KEZAR LIFE SCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $4,652,597 | +32.6% | 1,899,019 | +69.4% | 0.14% | +33.6% |
Q1 2023 | $3,509,782 | -27.8% | 1,121,336 | +62.4% | 0.11% | -28.2% |
Q4 2022 | $4,860,282 | +26.2% | 690,381 | +54.3% | 0.15% | +18.3% |
Q3 2022 | $3,852,000 | +68.7% | 447,418 | +62.0% | 0.13% | +61.5% |
Q2 2022 | $2,284,000 | -19.0% | 276,164 | +62.8% | 0.08% | +11.4% |
Q1 2022 | $2,820,000 | +45.1% | 169,685 | +46.0% | 0.07% | +75.0% |
Q4 2021 | $1,944,000 | – | 116,262 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 9,303,840 | $22,794,408 | 3.42% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,030,342 | 2.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $17,560,598 | 0.94% |
SPHERA FUNDS MANAGEMENT LTD. | 1,988,228 | $4,871,159 | 0.76% |
Avidity Partners Management LP | 6,080,000 | $14,896,000 | 0.52% |
Ikarian Capital, LLC | 841,596 | $2,061,910 | 0.33% |
Orbimed Advisors | 5,463,000 | $13,384,350 | 0.24% |
Granahan Investment Management | 1,899,019 | $4,652,597 | 0.14% |
Palo Alto Investors LP | 656,200 | $1,607,690 | 0.13% |
Opaleye Management Inc. | 98,796 | $242,050 | 0.06% |